The retention and secondary use of residual newborn screening (NBS) dried blood samples without parental consent have generated controversy and resulted in lawsuits against health departments in Texas, Minnesota and Indiana. This manuscript summarizes the legal issues raised in the litigation and highlights additional parental concerns.